Key result
Chronic supplementation with n-3 PUFAs reduced infarct size by 30.6% and 48.5% in a dose-dependent manner in a rat model of myocardial ischaemia-reperfusion injury (p < 0.05).
Why the study?
Does chronic supplementation with n-3 PUFAs reduce infarct size and improve oxidative stress in a rat model of myocardial ischaemia-reperfusion injury?
Does chronic supplementation with n-3 PUFAs reduce infarct size and improve oxidative stress in a rat model of myocardial ischaemia-reperfusion injury?
Effect estimate: 30.6% (D1) and 48.5% (D2) reduction in IS
p-value: p=<0.05
Chronic supplementation with n-3 PUFAs induces cardioprotection against ischaemia-reperfusion injury in rats by reinforcing the antioxidant defense system.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for n-3 PUFA cardioprotection; leaves open translation from rat models to clinical ischaemia-reperfusion injury.
Castillo et al. (2013) studied Myocardial ischaemia-reperfusion injury (n=21). n-3 polyunsaturated fatty acids (PUFAs) vs. Standard diet was evaluated on Infarct size (IS) and left ventricular function (30.6% (D1) and 48.5% (D2) reduction in IS, p=<0.05). Chronic supplementation with n-3 PUFAs reduced infarct size by 30.6% and 48.5% in a dose-dependent manner in a rat model of myocardial ischaemia-reperfusion injury (p < 0.05).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: